Covered recipient · General Payments record
RHETT L BROWN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,407.75
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $369.98 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $134.68 | 3 |
| Gilead Sciences, Inc. | $47.03 | 2 |
| Abbott Laboratories | $45.87 | 3 |
| Lilly USA, LLC | $32.68 | 2 |
| SANOFI-AVENTIS U.S. LLC | $27.46 | 1 |
| ViiV Healthcare Company | $25.55 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $25.06 | 1 |
| Merck Sharp & Dohme Corporation | $16.41 | 1 |
| PFIZER INC. | $15.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.80 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125347736 | CMS |
| Abbott Laboratories | $14.62 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125347738 | CMS |
| Abbott Laboratories | $14.45 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125347740 | CMS |
| Gilead Sciences, Inc. | $16.25 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133740584 | CMS |
| Gilead Sciences, Inc. | $30.78 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133740586 | CMS |
| Lilly USA, LLC | $18.41 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135363785 | CMS |
| Lilly USA, LLC | $14.27 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135365108 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $25.06 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154675885 | CMS |
| Merck Sharp & Dohme LLC | $16.41 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141833341 | CMS |
| Novo Nordisk Inc | $5.49 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096637422 | CMS |
| Novo Nordisk Inc | $4.18 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097045908 | CMS |
| Novo Nordisk Inc | $125.01 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096791255 | CMS |
| PFIZER INC. | $15.24 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131166109 | CMS |
| SANOFI-AVENTIS U.S. LLC | $27.46 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140012780 | CMS |
| ViiV Healthcare Company | $25.55 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112780340 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.